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Abstract 
Background: To systematically evaluate the therapeutic effect of electrical stimulation (ES) on overactive bladder 
(OB).
Method: We retrieved information by searching databases from PubMed, CBM-disc, The Cochrane Library, Science-
Direct (from Elsevier publishers) and Springer publishers up to March 2016. We looked for randomized controlled trials 
that studied ES in OB treatment with subject headings and keywords using literature searches and manual retrieval. 
References of included studies were reviewed. Literature was screened independently by two investigators according 
to inclusion and exclusion criteria. After extracting data and evaluating their quality, meta-analysis was undertaken 
with RevMan v5.2.
Results: Ten randomized controlled trials involving 719 patients were included. Meta-analysis results demonstrated 
ES to have better effects for improving bladder compliance, reducing residual urine, and decreasing the frequency of 
enuresis in OB patients compared with the control group. ES elicited significantly better effects for diminishing the 
maximum detrusor pressure in children than in controls, but there was no significant difference in the maximum det-
rusor pressure between adults and controls. The therapeutic effect of ES combined with other therapies for increasing 
the maximum bladder capacity was better compared with other therapies alone. No significant difference was noted 
between ES alone and other therapies alone.
Conclusions: Based on current evidence, ES has certain effects on OBs. Severe adverse reactions are not observed. ES 
is safe, efficacious, and worthy of clinical use.
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Background
Urgency is the main clinical manifestation of overactive 
bladder (OB). Often, OB is accompanied by frequent uri-
nation and enuresis, and may be associated with/without 
urge incontinence. OB can be expressed as overactivity 
of detrusor muscle or other forms of urethra–bladder 
dysfunction (Abrams et  al. 2002). Excessive activity of 
the bladder can result if uncontrolled suppression and 
abnormal excitement occur in the central nervous sys-
tem, peripheral nervous system, or smooth muscle of 
the bladder. Often, OB is accompanied by dysfunction 
of the bladder and urethra. Such dysfunction can induce 
an infection in the urinary tract, stones or ureteral reflux 
which, if severe, may result in death due to renal failure. 
Often, urgency, urinary frequency and urinary incon-
tinence reduce the ability to work and to participate 
in social activities, and can result in a poor social func-
tioning. Therefore, restoration of urinary continence is 
important for improving the quality and prolongation of 
the lives of OB patients.
Conventional treatments for OB are drug therapy, blad-
der rehabilitation training, and surgery. Drug treatment 
is based mainly on anticholinergic agents. The efficacy of 
these drugs is good, but often the patient cannot adhere 
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to medication because of adverse reactions (Pelletier 
et  al. 2009). Bladder rehabilitation training can take a 
long time, and often the effect is not satisfactory. Surgery 
is traumatic, is associated with complications, and is not 
accepted by some patients.
In recent decades, electrical stimulation (ES) has been 
developed and used for treatment of dysfunction of the 
lower urinary tract. Several studies have shown ES to 
be effective for treating dysfunction of the lower uri-
nary tract by increasing the capacity or compliance of 
the bladder or possibly by decreasing detrusor pressure 
(Bosch and Groen 1998; Amaro et  al. 2006; Lee et  al. 
2012a).
However, some questions regarding ES need to be 
answered: can ES improve bladder function-related indi-
cators? What is the degree of improvement? Are there 
differences in therapeutic effects comparable with con-
ventional treatment? What are the adverse reactions of 
ES? Is ES safe? Can ES be an alternative to conventional 
treatment?
This study sought to: (1) summarize the findings of 
published randomized controlled trials (RCTs); (2) com-
prehensively and objectively understand the therapeutic 
effect of ES for bladder dysfunction; (3) provide effective 
guidance for clinical treatment.
Methods
Study design
The present study was based on RCTs regardless of 
whether a blinding method was used.
Study subjects
Urgency is the main clinical manifestation of OB. Often, 
OB is accompanied by frequent urination and enuresis, 
and may be with or without urge incontinence. OB can 
be expressed as overactivity of detrusor muscle or other 
forms of urethra–bladder dysfunction.
Interventions
The trial group underwent ES or ES combined with other 
therapies irrespective of stimulation mode, parameter 
setting, or treatment course. The control group under-
went other therapies (except ES), such as anticholinergic 
drugs and ES without an electric current.
Exclusion criteria
There were six exclusion criteria: (1) duplicate detection 
or duplicate publication; (2) non-RCTs; (3) case–con-
trol study; (4) Review-, Discussion- or Comment-type 
articles; (5) raw data could not be used; (6) useful data 
could not be obtained by contacting the corresponding 
author.
Outcome measures
Outcome measures were: (1) maximum bladder capacity; 
(2) maximum detrusor pressure; (3) bladder compliance; 
(4) residual urine; (5) enuresis.
Retrieval strategy
We retrieved information by searching databases from 
PubMed, CBM-disc, The Cochrane Library, ScienceDi-
rect (from Elsevier publishers) and Springer publishers 
up to March 2016. We looked for RCTs that studied ES in 
the treatment of OB with subject headings and keywords 
using literature searches and manual retrieval. Search 
terms were: “nerve stimulation”, “electrical stimulation”, 
“neuromodulation”, “electroacupuncture”, “incontinence”, 
“lower urinary tract dysfunction”, “neurogenic blad-
der”, “urinary retention”, “multiple sclerosis”, “spinal cord 
injury”, “cerebral vascular disease”, “Parkinson’s disease”, 
“Alzheimer’s disease”, “detrusor hyperreflexia”, “detrusor 
overactivity”, and “detrusor sphincter dyssynergia”.
Document screening and data extraction
Literature was screened independently by two investi-
gators according to the inclusion and exclusion criteria 
described above. Information was collected with a pre-
designed data-extraction form that included: (1) basic 
information (author, publication year, baseline data); (2) 
trial design, interventions, measurement index and dura-
tion of follow-up. Disagreements were resolved by dis-
cussion or through consensus with a third investigator. 
Incomplete information was supplemented by contacting 
the corresponding author of the article. If we could not 
obtain original data, the study was excluded.
Assessment of methodological quality of included studies
The risk of bias of the included RCTs was evaluated 
independently with the bias risk-assessment tool in the 
Cochrane Handbook for Systematic Reviews of Inter-
ventions (v5.1.0) by two researchers. Contents include 
whether: (1) the correct method of randomization has 
been adopted; (2) allocation concealment has been 
used; (3) intervention measures have been implemented 
by a blinded method; (4) outcome indicators have been 
evaluated by a blinded method; (5) all results have been 
reported (number of patients lost to follow-up, number 
of dropouts, intent-to-treat analysis); (6) there has been 
selective reporting of results; (7) there are other sources 
of bias. Disagreements were resolved by discussion or 
through consensus with a third investigator.
Statistical analyses
Data were analyzed using RevMan v5.2. Measurement 
data used the mean difference (MD) or standardized 
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mean difference (SMD) and its 95% confidence interval 
(CI). Count data used odds ratios (ORs) and 95% CI for 
efficacy analyses. Heterogeneity testing among results 
was conducted with the χ2 test. For statistical homo-
geneity (P  >  0.1, I2  <  50%), a meta-analysis was done 
using fixed-effect models. For statistical heterogeneity 
(P < 0.1, I2 > 50%), the source of heterogeneity was ana-
lyzed, and a subgroup analysis of the factors that might 
lead to heterogeneity was carried out. If there was sta-
tistical heterogeneity among study results but clinical 
heterogeneity was absent, a meta-analysis was under-
taken using random-effect models. If the heterogene-
ity between the two groups was too large or we could 
not find the data source, descriptive analysis was used. 




A total of 1583 studies were screened primarily. 1558 
studies were excluded by eliminating duplication, and 
reading the title and abstract. Finally, 10 RCTs involv-
ing 719 patients were included by reading the full-text. A 
flowchart and results of literature screening are displayed 
in Fig. 1. Basic characteristics of each study are listed in 
Table 1 (Chen et al. 2015; McClurg et al. 2008; Kajbafza-
deh et al. 2009, 2014; Meng et al. 2015; Yamanishi et al. 
2000; Chen et  al. 2012; Peters et  al. 2009, 2010; Arruda 
et al. 2008).
The 10 studies compared baseline data between the 
trial group and control group. Of these studies, six stud-
ies reported the duration of disease (the shortest was 
1 year, and the longest was 10 years). Six studies reported 
the reasons for OB. Injury to the spinal cord was noted 
in two studies, spinal myelomeningocele in two studies, 
multiple sclerosis in one study, and Parkinson’s disease 
in one study. The shortest duration of ES was 2  weeks 
and the longest was 12 weeks. Among seven studies, the 
difference was only in the effect of ES and, in the other 
three studies, the difference was between ES and other 
treatments. The ES mode was percutaneous stimulation 
of the tibial nerve in three studies, neuromuscular ES 
in one study, functional ES in two studies, interferential 
electrostimulation in one study, electroacupuncture in 
two studies, and dorsal penile/clitoral nerve stimulation 
in one study.
Assessment of the methodological quality of included 
studies




For statistical heterogeneity among study results, sub-
group analysis was conducted according to different 
interventions. For statistical homogeneity, random-effect 
models were used in the meta-analysis (Fig.  3). Results 
demonstrated significant differences in maximum blad-
der capacity between the two groups (ES +  other ther-
apies vs. other therapies) [SMD  =  0.52, 95% CI (0.22, 
0.81), P = 0.00006]. Mean bladder capacity of the treat-
ment group increased by 45.6  mL, and the maximum 
increase was 130.4 mL. Mean bladder capacity of the con-
trol group increased by 14.6 mL, the maximum increase 
was 74.9  mL, and the maximum reduction was 85  mL. 
However, there was no significant difference in maximum 
bladder capacity in the ES group vs. other treatment 
group [SMD = −0.36, 95% CI (−1.30, 0.59), P =  0.46]. 
These findings suggested that ES combined with conven-
tional therapy elicited better outcomes for increasing the 
maximum bladder capacity in OB patients than that in 
the control group. However, no significant difference was 
found between ES alone and other treatment alone.
Maximum detrusor pressure
Five studies involving 195 patients were included for 
analyses of maximum detrusor pressure. For statistical 
heterogeneity among study results, subgroup analysis 
was conducted according to age. For statistical homo-
geneity, fixed-effect models were used in the meta-
analysis (Fig.  4). Results showed significant differences 
in the maximum detrusor pressure between children 
and controls [MD = −29.41, 95% CI (−45.87, −12.95), 
P  =  0.005], but no significant difference was identi-
fied between adults and controls [−4.06, (–10.20, 2.07), 
P =  0.19]. These results confirmed that ES elicited bet-
ter effects for reducing the maximum detrusor pressure 
in children with OB than that in controls, but no signifi-
cant difference was found between adults with OB and 
controls.
Bladder compliance
Three studies involving 117 patients were included for 
analyses of bladder compliance. For statistical homoge-
neity, fixed-effect models were used in the meta-analysis 
(Fig. 5). Results showed significant differences in bladder 
compliance between the two groups [MD = 3.18, 95% CI 
(0.09, 6.28), P  =  0.04]. Mean increase in the treatment 
group was 5.3 cmH2O/mL and in the control group was 
5.0 cmH2O/mL. These data suggested that ES elicited 
better effects for improving bladder compliance in OB 
patients compared with the control group.
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Fig. 1 Flowchart and results of literature screening
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Fig. 2 Assessment of the methodological quality of included studies
Fig. 3 Meta-analysis of the maximum bladder capacity in patients with overactive bladder in both groups after treatment
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Residual urine
Three studies involving 138 patients were included for 
analyses of residual urine. For statistical homogene-
ity, fixed-effect models were used in the meta-analysis 
(Fig.  6). Results demonstrated significant differences in 
residual urine between the two groups [MD = 25.44, 95% 
CI (13.78, 37.09), P  <  0.0001]. In the treatment group, 
the mean reduction was 47.4  mL, and the maximum 
reduction was 62.3  mL. In the control group, the mean 
reduction was 15.3 mL, and the maximum reduction was 
30.9 mL. These results suggested that ES elicited effects 
for reducing residual urine in OB patients compared with 
those in the control group.
Frequency of enuresis
Five studies involving 394 patients were included for anal-
yses of enuresis. For statistical homogeneity, fixed-effect 
models were used in the meta-analysis (Fig.  7). Results 
demonstrated significant differences in the frequency of 
enuresis between the two groups [SMD = –0.21, 95% CI 
(–0.41, –0.01), P  =  0.04]. Mean reduction in the treat-
ment group was 0.9 times, and in the control group was 
0.5 times. These data suggested that ES elicited bet-
ter effects for reducing the frequency of enuresis in OB 
patients than those in controls.
Adverse reactions
Six studies reported adverse reactions to ES, which were 
fecal incontinence, discomfort, and muscle spasm at 
the site of stimulation (Chen et  al. 2012). Adverse reac-
tions to anticholinergic drugs included dry mouth, dry 
eyes and blurred vision (McClurg et al. 2008; Peters et al. 
2009). Autonomic nerve reflexes and pyrexia appeared 
during injection of botulinum toxin type A, (Yamanishi 
et  al. 2000) but severe adverse reactions did not occur. 
Three studies did not report obvious adverse reactions. 
The remaining study did not report adverse reactions.
Discussion
Causes of OB are mainly neurogenic: injury to the spinal 
cord, multiple sclerosis, or spinal meningocele. Treat-
ment of neurogenic bladder is very challenging. Some 
methods have been used (e.g., drugs, bladder rehabilita-
tion training, surgery) but outcomes have been barely 
Fig. 4 Meta-analysis of the maximum detrusor pressure in patients with overactive bladder in both groups after treatment
Fig. 5 Meta-analysis of bladder compliance in patients with overactive bladder in both groups after treatment
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satisfactory. Moreover, long-term treatment is expen-
sive, so many patients and their families cannot adhere 
to treatment. Thus, more effective treatment methods for 
OB have been studied.
In 1954, Boyce was the first to use ES: he employed ES 
in the bladder wall. In 1963, Caldwen undertook treat-
ment of urinary incontinence. ES stimulates nerves and 
muscles with an electric current to initiate nerve reflexes 
and muscle contractions. In this way, the structure and 
function of the detrusor of the bladder, urethral sphincter 
and pelvic floor are altered (Craggs and McFarlane 1999). 
ES can be classified into stimulation at sacral nerves, pel-
vic floor, tibial nerve, or pudendal nerve.
The main functions of the lower urinary tract are 
urine storage and periodic urination, which are accom-
plished through the bladder and urethra, respectively. 
The lower urinary tract is controlled simultaneously by 
the sympathetic nerve (T10–L2), somatic nerve (S2–4), 
parasympathetic nerve (S2–4), the pontine micturition 
center, and the cerebral cortex. The bladder is also con-
trolled by pelvic afferent nerves, which comprise mainly 
myelinated Aδ nerve fibers and some unmyelinated C 
nerve fibers. Somatic nerves mainly conduct sensations 
and pressure within the bladder. Coordination of sympa-
thetic and somatic nerves controls bladder relaxation and 
sphincter contraction to achieve urine storage. Parasym-
pathetic nerves primarily control detrusor, external ure-
thral sphincter, and perineal muscles. The cerebral cortex 
sends messages on urine storage or micturition to the 
pontine micturition center. The latter controls the syn-
ergy between detrusor and urethral sphincters.
The main principle of ES is to activate peripheral sen-
sory and motor nerves to produce sensations and muscle 
contractions, as well as to activate different spinal reflex 
zones or other central nervous systems, thereby resulting 
in the corresponding effect. Transmembrane currents are 
produced using an artificial external current to the outer 
membranes of neural cells or nerve fibers, thereby result-
ing in depolarization. If the current amplitude reaches a 
threshold value or less, it can stimulate action potentials, 
produce nervous excitation, and affect the particular 
organ. Therefore, urination by ES of nerve fibers is feasi-
ble. In accordance with the electrophysiological proper-
ties of the bladder and lower urinary tract, patients with 
bladder dysfunction have been subjected to ES. That is, 
during the micturition period, EC activates the motor 
nerve fibers that dominate the detrusor, cause bladder 
contraction, increase the pressure within the bladder, 
and promote bladder emptying. During the urine-stor-
age period, EC suppresses the abnormal detrusor reflex, 
activates the muscles of the closed urethra, and prevents 
urine leakage (Jezernik et al. 2002).
Of the 10 RCTs included in our meta-analysis, five 
studies described the randomization method and pro-
cedure precisely,but only one study described allocation 
concealment. The remaining five studies mentioned only 
the method of randomization. Seven studies used a blind-
ing method, including six double-blinded studies (mainly 
Fig. 6 Meta-analysis of residual urine in patients with overactive bladder in both groups after treatment
Fig. 7 Meta-analysis of the frequency of enuresis in patients with overactive bladder in both groups after treatment
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subject-blinded and evaluator-blinded). Reported data of 
one study were incomplete. All studies reported dropouts 
and the number of patients lost to follow-up. Only four 
studies reported the duration of follow-up. Most studies 
compared baseline data (e.g., patient age, proportion of 
males and females) and results demonstrated that base-
line data were comparable between the trial group and 
control group. The methodological quality of most stud-
ies was high, so the results of this meta-analysis are a 
good reference for further studies.
The 10 RCT studies involving 719 patients mainly 
analyzed the efficacy and safety of ES for OB treatment. 
Our results showed that ES elicited better effects in 
OB patients than those in the control group because it 
increased bladder compliance and reduced residual urine 
and enuresis frequency. The effects of ES on reducing the 
maximum detrusor pressure were better in children than 
in controls, but a significant difference was not observed 
between adults and controls. The effects of ES combined 
with other therapies on increasing the maximum blad-
der capacity were better than for other therapies alone, 
but no significant difference was noted between ES alone 
and other therapies alone. In addition, we observed that, 
in male-dominated studies, ES mainly improved the blad-
der capacity whereas, in female-based studies, bladder 
compliance was also improved significantly in addition 
to bladder capacity. In children, ES improved the bladder 
capacity, mean maximum detrusor pressure, mean blad-
der compliance, and enuresis whereas, in adults, the main 
improvements were on the bladder capacity and enuresis.
Only one study of the 10 RCTs reported the adverse 
reactions to ES: fecal incontinence, discomfort and mus-
cle spasm at the site of stimulation (Chen et  al. 2012). 
However, adverse reactions may be different in differ-
ent stimulation modes. Initially, the most widely used 
method is to stimulate sacral nerve roots. Such ES 
requires implantation of an electrical stimulator in the 
patient combined with resection of sacral nerve roots. 
The effect is obvious, but it can cause penile erection 
and ejaculation dysfunction, and this type of surgery is 
irreversible. Moreover, infection, pain, and failure of the 
electrode device can appear at the implant site (Bosch 
and Groen 2000; Kutzenberger 2007; Wang et  al. 2007; 
Hino et al. 2010). Medical and engineering advances has 
led to minimally invasive (and even non-invasive surface) 
ES, (Lee et  al. 2012b; Hagerty et  al. 2007; Radziszewski 
et al. 2009; Radziszewski 2013; Gobbi et al. 2011) and ES 
can be used widely. Overall, the prevalence of adverse 
reactions of ES is low less: no deaths have been reported. 
Therefore, ES appears to be very safe.
Our meta-analysis demonstrated no significant dif-
ferences between ES and other therapies with respect 
to the maximum bladder capacity and maximum 
detrusor pressure. However, these data do not mean 
that ES had no effect. Results of the 10 RCTs showed 
that ES was effective in improving bladder func-
tion and the symptoms of urinary incontinence, data 
that are in accordance with the outcomes of non-
RCTs (Lombardi and Del Popolo 2009; Kabay et  al. 
2008, 2009). Studies have shown that the therapeutic 
effects of implantable sacral anterior root stimula-
tion combined with sacral posterior root resection are 
remarkable, but such stimulation is invasive, requires 
considerable surgical skill, and is expensive. Such stud-
ies were not included in our meta-analysis because 
they were non-RCTs. According to the literature, the 
practical effects of ES in OB treatment should be bet-
ter than that shown in our meta-analysis. Hence, to 
improve ES efficacy, scholars need to improve the 
methodology of further studies.
We found that the parameter settings of ES were dif-
ferent in different studies, as were the therapeutic effects. 
Irrespective of the type of ES used, there were no stand-
ard parameter settings, so the effects were limited. We 
consider treatment with ES to be in the exploratory stage. 
We cannot provide clear conclusions on the optimal form 
of ES and how to setup the relevant parameters of ES to 
maximize its therapeutic effect. Hence, ES cannot replace 
conventional therapy, but can be used as adjunctive ther-
apy. We suggest that future studies should focus on six 
main areas. First, more refined ES will stimulate muscles 
and nerves accurately. Second, animal experiments can 
help to define the optimal parameters in various types 
of ES. Third, after identification of optimal ES, studies 
focusing on optimal ES and other therapies should be 
carried out to: maximize the therapeutic effect; shorten 
the treatment course; reduce the incidence of compli-
cations. Fourth, ES should be non-invasive. Fifth, close 
attention should be paid to improvement in the psy-
chology, emotional state, and quality of life of patients. 
Finally, the effects of ES on improving the bladder func-
tion, physical activity and social inclusion of OB patients 
should be verified.
Our meta-analysis had seven main limitations. First, 
the number of RCTs and patients was small. Second, the 
included studies had been published. Third, we did not 
retrieve relevant “gray” literature. Fourth, RCTs with 
negative results may not have been published. Fifth, the 
duration of follow-up, illness, and treatment were not 
completely consistent in patients from different studies. 
Sixth, most studies did not describe allocation conceal-
ment. These six limitations could have resulted in bias 
in research findings. Seventh, because of the small num-
ber of RCTs, we compared and evaluated only ES and 
other therapies, and did not study the effects of different 
types and parameter settings of ES on outcomes. Taken 
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together, the conclusions of our meta-analysis can be 
used only as a clinical reference.
Conclusions
ES has certain effects on OBs, and severe adverse reac-
tions have not been observed. Thus, ES is safe, effica-
cious, and worthy of clinical use. Limited by the quality 
and quantity of included RCTs, our conclusions should 
be confirmed by rigorously designed randomized, dou-
ble-blind, controlled trials (especially large-sample, mul-
ticenter, randomized, double-blind, controlled trials).
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